Company intelligence / Profile preview

Recōdagen

Seattle, Washington, United Statesrecodagen.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Recōdagen develops novel therapies targeting cancer by focusing on unique tumor cell–specific proteins not present in normal adult tissues. Their lead program centers around the Mig7 protein—expressed only in invasive tumor cells and certain pregnancy cells—aiming to prevent metastasis with minimal side effects. The company leverages a proprietary platform that identifies functional proteins encoded by so-called “noncoding” RNAs. Additional research efforts are underway for neurodegenerative diseases like Alzheimer’s and autoimmune conditions. No clinical-stage data has been reported publicly.

Therapeutic areas: OncologyNeurology
Modalities: Protein therapeutics (targeting cancer-specific proteins)Potentially others related to gene expression modulation and noncoding RNA-derived proteins
Industry: Biotech

Partnerships

Accelerator Corporation was instrumental in founding/investing; initial investors include Alexandria Real Estate Equities, Amgen Ventures, ARCH Venture Partners, OVP Venture Partners, WRF Capital.

Beyond the preview

Go deeper on Recōdagen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Recōdagen.

Explore the full profile